[Plasminogen activator-inhibitor 1: biochemical, structural and functional studies]

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Context:

• Plasminogen activator inhibitor-1 (PAI-1) is a key regulator of the fibrinolytic system.
• PAI-1 circulates in plasma and is stored in platelets, with distinct active and inactive forms.
• Understanding PAI-1's various conformations and interactions is crucial for comprehending its biological roles.

Purpose:

• To develop and utilize monoclonal antibodies for characterizing PAI-1.
• To investigate the distribution and activity states of PAI-1 in plasma and platelets.
• To identify and characterize PAI-1 binding proteins and their functional significance.
• To explore the conformational transitions of PAI-1 and their impact on its function.

Summary:

• Monoclonal antibodies were generated against PAI-1, enabling the development of sensitive assays and purification techniques.
• Data indicate PAI-1 is primarily found in platelets (92%) as an inactive form, while plasma contains mainly active PAI-1 (8%).
• Vitronectin was identified as a PAI-1 binding protein in plasma, stabilizing active PAI-1 and mediating its binding to the extracellular matrix.
• Novel PAI-1 conformations, including a substrate form, were characterized, revealing unique functional properties and implications for fibrinolysis regulation.
• Conformational changes, particularly in the P12-P9 region, significantly influence PAI-1's functional properties.

Impact:

• The findings provide insights into the regulation of fibrinolysis by PAI-1 and its interactions with vitronectin.
• Understanding PAI-1's different forms and their regulation may have implications for diseases involving aberrant fibrinolysis, such as tumor metastasis.
• Characterization of PAI-1's unique conformational properties opens new avenues for therapeutic strategies targeting the fibrinolytic system.